Smooth muscle-like tissues engineered with bone marrow stromal cells.

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Cell Biology

Background:

• Bone marrow-derived cells, including bone marrow stromal cells (BMSCs), exhibit multipotent differentiation capabilities.
• The potential for BMSCs to form smooth muscle (SM) tissues in vivo remains an area of active investigation for regenerative medicine applications.

Purpose of the Study:

• To investigate the feasibility of engineering smooth muscle-like tissues in vivo using canine bone marrow stromal cells (BMSCs).
• To evaluate the differentiation potential and tissue formation capacity of BMSCs when seeded on biodegradable scaffolds.

Main Methods:

• Canine BMSCs, expressing SM cell markers (SM alpha-actin, SM myosin heavy chain), were cultured and seeded onto 3D biodegradable polymer scaffolds.
• Cell-seeded scaffolds were implanted into the peritoneal cavity of athymic mice.
• Constructs were retrieved after 4 weeks for histological and immunohistochemical analyses, including Masson's trichrome staining and fluorescent tracer assessment.

Main Results:

• Implanted cell-scaffold constructs successfully formed three-dimensional tissues within 4 weeks.
• The engineered tissues expressed key smooth muscle markers (SM alpha-actin, SM myosin heavy chain) and significant amounts of collagen.
• Implanted cells remained viable and present within the engineered tissues after 4 weeks, unlike non-seeded control scaffolds.

Conclusions:

• Bone marrow stromal cells (BMSCs) demonstrate significant potential for the in vivo engineering of smooth muscle-like tissues.
• This study supports the use of BMSCs as a viable cell source for developing novel regenerative therapies for smooth muscle defects.